1. Home
  2. Analysis
  3. Donepezil
  4. Arnuity-ellipta

Donepezil and Arnuity ellipta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Donepezil (donepezil hydrochloride) and Arnuity ellipta (fluticasone furoate). Common drug interactions include chest pain among females.

The phase IV clinical study analyzes what interactions people have when they take Donepezil and Arnuity ellipta. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Donepezil?

Donepezil has active ingredients of donepezil hydrochloride. It is often used in dementia. eHealthMe is studying from 24,564 Donepezil users. Check the latest studies of Donepezil.

What is Arnuity ellipta?

Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 3,482 Arnuity ellipta users. Check the latest studies of Arnuity ellipta.

On Jul, 17, 2026

11 people who take Donepezil and Arnuity ellipta together, and have interactions are studied.

Donepezil and Arnuity ellipta drug interactions.

What are the common drug interactions of Donepezil and Arnuity Ellipta, by gender? *:

female:

  1. Chest pain
  2. Abdominal discomfort
  3. Hallucination (an experience involving the perception of something not present)
  4. Chronic respiratory failure
  5. Tremor (trembling or shaking movements in one or more parts of your body)

male:

n/a

What are the common drug interactions of Donepezil and Arnuity Ellipta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Chest pain
  2. Abdominal discomfort
  3. Hallucination (an experience involving the perception of something not present)
  4. Chronic respiratory failure
  5. Tremor (trembling or shaking movements in one or more parts of your body)

What are the existing conditions these people have? *

  1. Stress And Anxiety: 7 people, 63.64%
  2. Seasonal Allergy (allergic condition due to certain season): 7 people, 63.64%
  3. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 7 people, 63.64%
  4. High Blood Pressure: 7 people, 63.64%
  5. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 7 people, 63.64%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 63.64%
  7. Parkinson's Disease: 3 people, 27.27%
  8. High Blood Cholesterol: 1 person, 9.09%
  9. Asthma: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Donepezil and Arnuity ellipta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Donepezil and Arnuity ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Donepezil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Arnuity ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Donepezil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arnuity ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on donepezil hydrochloride and fluticasone furoate (the active ingredients of Donepezil and Arnuity ellipta, respectively), and Donepezil and Arnuity ellipta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.